ALMODAWAT

Almodawat Specialized Medical Hospital Company

9594StocksTadawulHealthcare

Financials

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Quarterly (SAR)

1-5

	Q1 2026Mar 31, 2026	Q4 2025Dec 31, 2025	Q3 2025Sep 30, 2025	Q2 2025Jun 30, 2025	Q1 2025Mar 31, 2025
Operations
Operating Cash Flow	-5.26M	2.48M	-1.59M	2.47M	0.29M
Free Cash Flow	-9.42M	14.88M	-4.39M	-2.03M	-7.17M
Capital Expenditures	-4.16M	12.40M	-2.80M	-4.51M	-7.46M
Investing & Financing
Investing Cash Flow	-4.16M	12.39M	-1.82M	-4.52M	-7.46M
Financing Cash Flow	0.26M	13.57M	-4.33M	5.33M	-1.46M
Dividends Paid	-2.14M	-2.14M	-0.71M	—	—
Share Repurchase	-114.91K	—	-448.71K	—	-377.18K
Operating Activities
Operating Cash Flow	-5.26M	2.48M	-1.59M	2.47M	0.29M
Net Income	2.87M	5.02M	3.61M	4.82M	5.53M
Change in Accounts Payable	2.26M	0.14M	0.14M	1.70M	1.74M
Change in Accounts Receivable	-11.88M	-12.76M	-7.36M	-8.90M	-6.56M
Change in Inventory	-1.58M	0.98M	-1.06M	-0.27M	-0.84M
Change in Other Net Operating Assets	-0.02M	6.19M	-2.03M	4.53M	-3.84M
Change in Working Capital	-11.21M	-5.45M	-10.31M	-2.94M	-9.50M
Other Operating Activities	0.18M	-0.32M	2.60M	-1.44M	1.98M
Provision & Write-off of Bad Debts	629.72K	-593.62K	247.28K	34.45K	311.89K
Depreciation & Amortization	2.26M	2.07M	2.11M	2.08M	1.96M
Other Amortization	5.92K	5.91K	5.39K	10.63K	5.29K
Cash Interest Paid	—	710.30K	412.77K	218.53K	—
Miscellaneous Cash Flow Adjustments	—	-19.00M	—	—	—
Investing Activities
Investing Cash Flow	-4.16M	12.39M	-1.82M	-4.52M	-7.46M
Capital Expenditures	-4.16M	12.40M	-2.80M	-4.51M	-7.46M
Cash Acquisitions	—	—	—	-7.75K	—
Investment in Securities	—	—	1.00M	—	—
Other Investing Activities	—	—	—	—	—
Sale (Purchase) of Intangibles	-1.40K	-2.74K	-20.52K	—	-2.50K
Loss (Gain) From Sale of Assets	—	72.42K	54.68K	—	—
Loss (Gain) on Sale of Investments	—	—	94.73K	-93.91K	—
Financing Activities
Financing Cash Flow	0.26M	13.57M	-4.33M	5.33M	-1.46M
Common Dividends Paid	-2.14M	-2.14M	-0.71M	—	—
Issuance of Common Stock	—	0.09M	—	—	0.00M
Repurchase of Common Stock	-114.91K	—	-448.71K	—	-377.18K
Long-Term Debt Issued	4.09M	—	—	—	—
Total Debt Issued	4.09M	25.18M	—	10.92M	—
Long-Term Debt Repaid	-1.00M	—	—	—	-0.95M
Total Debt Repaid	-1.00M	-8.85M	-2.76M	-5.37M	-0.95M
Net Debt Issued (Repaid)	3.09M	16.33M	-2.76M	5.55M	-0.95M
Other Financing Activities	-579.43K	-710.30K	-412.77K	-218.53K	-133.06K
Free Cash Flow & Returns
Free Cash Flow	-9.42M	14.88M	-4.39M	-2.03M	-7.17M
Free Cash Flow Growth	—	+300.6%	—	—	—
Free Cash Flow Margin	-27.0%	+40.0%	-14.9%	-7.7%	-25.0%
Free Cash Flow Per Share	-0.13	0.21	-0.06	-0.03	-0.10
Levered Free Cash Flow	-13.92M	17.84M	-6.64M	-2.71M	-10.25M
Unlevered Free Cash Flow	-13.29M	18.27M	-6.31M	-2.40M	-10.06M
Operating Cash Flow Growth	—	-72.1%	—	—	-96.7%
Net Cash Flow	-9.16M	9.44M	-7.75M	3.29M	-8.63M

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Quarterly (SAR)

1-5

	Q1 2026Mar 31, 2026	Q4 2025Dec 31, 2025	Q3 2025Sep 30, 2025	Q2 2025Jun 30, 2025	Q1 2025Mar 31, 2025
Operations
Operating Cash Flow	-5.26M	2.48M	-1.59M	2.47M	0.29M
Free Cash Flow	-9.42M	14.88M	-4.39M	-2.03M	-7.17M
Capital Expenditures	-4.16M	12.40M	-2.80M	-4.51M	-7.46M
Investing & Financing
Investing Cash Flow	-4.16M	12.39M	-1.82M	-4.52M	-7.46M
Financing Cash Flow	0.26M	13.57M	-4.33M	5.33M	-1.46M
Dividends Paid	-2.14M	-2.14M	-0.71M	—	—
Share Repurchase	-114.91K	—	-448.71K	—	-377.18K
Operating Activities
Operating Cash Flow	-5.26M	2.48M	-1.59M	2.47M	0.29M
Net Income	2.87M	5.02M	3.61M	4.82M	5.53M
Change in Accounts Payable	2.26M	0.14M	0.14M	1.70M	1.74M
Change in Accounts Receivable	-11.88M	-12.76M	-7.36M	-8.90M	-6.56M
Change in Inventory	-1.58M	0.98M	-1.06M	-0.27M	-0.84M
Change in Other Net Operating Assets	-0.02M	6.19M	-2.03M	4.53M	-3.84M
Change in Working Capital	-11.21M	-5.45M	-10.31M	-2.94M	-9.50M
Other Operating Activities	0.18M	-0.32M	2.60M	-1.44M	1.98M
Provision & Write-off of Bad Debts	629.72K	-593.62K	247.28K	34.45K	311.89K
Depreciation & Amortization	2.26M	2.07M	2.11M	2.08M	1.96M
Other Amortization	5.92K	5.91K	5.39K	10.63K	5.29K
Cash Interest Paid	—	710.30K	412.77K	218.53K	—
Miscellaneous Cash Flow Adjustments	—	-19.00M	—	—	—
Investing Activities
Investing Cash Flow	-4.16M	12.39M	-1.82M	-4.52M	-7.46M
Capital Expenditures	-4.16M	12.40M	-2.80M	-4.51M	-7.46M
Cash Acquisitions	—	—	—	-7.75K	—
Investment in Securities	—	—	1.00M	—	—
Other Investing Activities	—	—	—	—	—
Sale (Purchase) of Intangibles	-1.40K	-2.74K	-20.52K	—	-2.50K
Loss (Gain) From Sale of Assets	—	72.42K	54.68K	—	—
Loss (Gain) on Sale of Investments	—	—	94.73K	-93.91K	—
Financing Activities
Financing Cash Flow	0.26M	13.57M	-4.33M	5.33M	-1.46M
Common Dividends Paid	-2.14M	-2.14M	-0.71M	—	—
Issuance of Common Stock	—	0.09M	—	—	0.00M
Repurchase of Common Stock	-114.91K	—	-448.71K	—	-377.18K
Long-Term Debt Issued	4.09M	—	—	—	—
Total Debt Issued	4.09M	25.18M	—	10.92M	—
Long-Term Debt Repaid	-1.00M	—	—	—	-0.95M
Total Debt Repaid	-1.00M	-8.85M	-2.76M	-5.37M	-0.95M
Net Debt Issued (Repaid)	3.09M	16.33M	-2.76M	5.55M	-0.95M
Other Financing Activities	-579.43K	-710.30K	-412.77K	-218.53K	-133.06K
Free Cash Flow & Returns
Free Cash Flow	-9.42M	14.88M	-4.39M	-2.03M	-7.17M
Free Cash Flow Growth	—	+300.6%	—	—	—
Free Cash Flow Margin	-27.0%	+40.0%	-14.9%	-7.7%	-25.0%
Free Cash Flow Per Share	-0.13	0.21	-0.06	-0.03	-0.10
Levered Free Cash Flow	-13.92M	17.84M	-6.64M	-2.71M	-10.25M
Unlevered Free Cash Flow	-13.29M	18.27M	-6.31M	-2.40M	-10.06M
Operating Cash Flow Growth	—	-72.1%	—	—	-96.7%
Net Cash Flow	-9.16M	9.44M	-7.75M	3.29M	-8.63M